SII, Bharat Biotech cut Covid vaccine prices for private hospitals
New Delhi, April 9: The Serum Institute of India (SII) and Bharat Biotech on Saturday decided to cut the prices of the precaution dose of their respective Covid-19 vaccines — Covishield and Covaxin — to Rs 225 per shot for private hospitals after discussion with the government.
"We are pleased to announce that after discussion with the Central Government, Serum Institute of India has decided to revise the price of Covishield vaccine for private hospitals from Rs 600 to Rs 225 per dose," SII CEO Adar Poonawalla said in a tweet.
Also read | Covid booster dose for all adults at private vaccination centres from April 10
On Friday, the company had said that the precaution dose of its Covishield vaccine against Covid-19 will be priced at Rs 600 per shot for eligible individuals.
Bharat Biotech Co-Founder Joint Managing Director Suchitra Ella in a tweet said: "We welcome the decision to make available precautionary dose for all adults. In consultation with the Central Government, we have decided to revise the price of #COVAXIN from Rs 1,200 to Rs 225 per dose, for #privatehospitals."
SII and Bharat Biotech have been major suppliers of Covid-19 vaccines to the government so far.
The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose. According to the health ministry, so far, about 96 per cent of all those above the age of 15 years in India have received at least one vaccine dose, while about 83 per cent have received both doses.
Also read | RBI keeps repo, reverse repo rates unchanged for 11th time in row
-PTC News with agency inputs
